Biocompatible sulfated valproic acid-coupled polysaccharide-based nanocarriers with HDAC inhibitory activity-Reference-Cited by-同舟云学术

Biocompatible sulfated valproic acid-coupled polysaccharide-based nanocarriers with HDAC inhibitory activity

Published:2021-01 Issue: Volume:329 Page:717-730
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Kühne Marie,Lindemann Henry,Grune Christian,Schröder Daniel^ORCID,Cseresnyés Zoltán,Godmann Maren,Koschella Andreas,Figge Marc Thilo,Eggeling Christian,Fischer Dagmar,Heinze Thomas,Heinzel Thorsten

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference48 articles.

1. Drug Discovery Today;Heinzel;Dis. Mech.,2007

2. Pharmacological and Therapeutic Properties of Valproate

3. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

4. Valproic acid attenuates sepsis-induced myocardial dysfunction in rats by accelerating autophagy through the PTEN/AKT/mTOR pathway

5. Valproic acid exerts specific cellular and molecular anti-inflammatory effects in post-operative conjunctiva

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of biomimetic nanoparticles for macrophage repolarisation and phagocytosis in tumour immunotherapy;Chemical Engineering Journal;2024-10

2. Biopolymer-Based Nanomedicine for Cancer Therapy: Opportunities and Challenges;International Journal of Nanomedicine;2024-07

3. Direct Functionalization of Polysaccharide‐Based Xylan Phenyl Carbonate Nanoparticles with Tumor Cell Specific Antibodies;ChemBioChem;2024-02-14

4. Advances in the Delivery and Development of Epigenetic Therapeutics for the Treatment of Cancer;Molecular Pharmaceutics;2023-10-30

5. Histone Deacetylase Inhibitor (SAHA) Reduces Mortality in an Endotoxemia Mouse Model by Suppressing Glycolysis;International Journal of Molecular Sciences;2023-08-04